Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of oral cladribine capsules versus placebo in adults with generalized myasthenia gravis
CTR20243857Phase 3Active
- Sponsor
- Merck KGaA
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine in myasthenia gravis (MG), sponsored by Merck KGaA. Started Nov 2025; status: active.
02
Drugs
cladribine
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on CTR20243857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243857.